Sudeep Pharma: Category QIB offered 30,18,552 shares, applied 64,31,88,450 shares, with a subscription of 213.08x, and total amount raised is 38,141.08 Cr. Category HNI offered 22,63,912 shares, applied 26,42,37,275 shares, with a subscription of 116.72x, and total amount raised is 15,669.27 Cr. Category BHNI (10L+) offered 15,09,275 shares, applied 20,36,19,700 shares, with a subscription of 134.91x, and total amount raised is 12,074.65 Cr. Category SHNI (2L - 10L) offered 7,54,637 shares, applied 6,06,17,575 shares, with a subscription of 80.33x, and total amount raised is 3,594.62 Cr. Category Retail offered 52,82,463 shares, applied 8,26,61,300 shares, with a subscription of 15.65x, and total amount raised is 4,901.82 Cr. Category Total offered 1,05,64,927 shares, applied 99,00,87,025 shares, with a subscription of 93.71x, and total amount raised is 58,712.16 Cr.
Sudeep Pharma: For BHNI (10L+), 4,312 shares were reserved, 1,17,655 were applied, and the subscription was 27.29x. For SHNI (2L - 10L), 2,156 shares were reserved, 1,64,599 were applied, and the subscription was 76.34x. For Retail, 2,11,298 shares were reserved, 27,03,801 were applied, and the subscription was 12.80x. Total applications received were 29,86,055.
| Category | Offered | Applied | Times | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| QIB | 30,18,552 | 64,31,88,450 | 213.08x | 38,141.08 |
| HNI | 22,63,912 | 26,42,37,275 | 116.72x | 15,669.27 |
| BHNI (10L+) | 15,09,275 | 20,36,19,700 | 134.91x | 12,074.65 |
| SHNI (2L - 10L) | 7,54,637 | 6,06,17,575 | 80.33x | 3,594.62 |
| Retail | 52,82,463 | 8,26,61,300 | 15.65x | 4,901.82 |
| Total | 1,05,64,927 | 99,00,87,025 | 93.71x | 58,712.16 |
Last Updated : 25 Nov, 2025 05:57:00 PM
| Category | Reserved | Applied | Times |
|---|---|---|---|
| BHNI (10L+) | 4,312 | 1,17,655 | 27.29x |
| SHNI (2L - 10L) | 2,156 | 1,64,599 | 76.34x |
| Retail | 2,11,298 | 27,03,801 | 12.80x |
Total Applications: 2986055
IPO Investor Categories
- Qualified Institutional Buyers (QIB)
Institutions like banks, mutual funds, insurance companies, and other SEBI-registered entities fall under the QIB category. They typically invest large sums on behalf of clients or schemes. - Non-Institutional Investors (NII)
This group includes high-net-worth individuals (HNIs), NRIs, trusts, and companies that apply for shares worth more than ₹2 lakhs. Unlike QIBs, SEBI registration is not required.NII is further split into:
- sNII (Applications below ₹10 Lakhs)
Investors bidding between ₹2 lakhs and ₹10 lakhs fall in the Small NII (sHNI) bracket. One-third of the NII portion is set aside for them. - bNII (Applications above ₹10 Lakhs)
Investors applying for more than ₹10 lakhs are classified as Big NIIs (bHNI). Two-thirds of the NII shares are allocated to this sub-category.
- sNII (Applications below ₹10 Lakhs)
- Retail Individual Investors (RII)
Individuals or NRIs applying for shares up to ₹2 lakhs are considered retail investors and are part of the RII quota. - Employee (EMP)
This section is reserved for eligible employees of the company participating in the IPO. - Others
Includes eligible shareholders or specific investors with a reserved quota as per the IPO policy.
Quick Insights: Sudeep Pharma IPO
Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided herein is for informational purposes only and is provided by a2zipo.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. a2zipo.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. a2zipo.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. a2zipo.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.